[1]
|
Manns, M.P., Czaja, A.J., Gorham, J.D., Krawitt, E.L., Mieli-Vergani, G., Vergani, D., et al. (2010) Diagnosis and Management of Autoimmune Hepatitis. Hepatology, 51, 2193-2213. https://doi.org/10.1002/hep.23584
|
[2]
|
Alvarez, F., Berg, P.A., Bianchi, F.B., Bianchi, L., Burroughs, A.K., Can-cado, E.L., et al. (1999) International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Auto-immune Hepatitis. Journal of Hepatology, 31, 929-938. https://doi.org/10.1016/S0168-8278(99)80297-9
|
[3]
|
Abe, M., Onji, M., Kawai-Ninomiya, K., Michitaka, K., Matsuura, B., Hiasa, Y., et al. (2007) Clinicopathologic Features of the Severe Form of Acute Type 1 Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology, 5, 255-258.
https://doi.org/10.1016/j.cgh.2006.10.011
|
[4]
|
Umemura, T., Joshita, S., Saito, H., Yoshizawa, K., Norman, G.L., Tanaka, E., et al. (2019) KIR/HLA Genotypes Confer Susceptibility and Progression in Patients with Autoimmune Hep-atitis. JHEP Reports, 1, 353-560.
https://doi.org/10.1016/j.jhepr.2019.09.003
|
[5]
|
Furumoto, Y., Asano, T., Sugita, T., Abe, H., Chuganji, Y., Fu-jiki, K., et al. (2015) Evaluation of the Role of HLA-DR Antigens in Japanese Type 1 Autoimmune Hepatitis. BMC Gastroenterology, 15, Article No. 144.
https://doi.org/10.1186/s12876-015-0360-9
|
[6]
|
Katsumi, T. and Ueno, Y. (2022) Epidemiology and Surveillance of Autoimmune Hepatitis in Asia. Liver International, 42, 2015-2022. https://doi.org/10.1111/liv.15155
|
[7]
|
Zhang, H.P., Liu, Y.M., Li, Z., Ma, Y.X., Li, L.J., Zhao, D.T., et al. (2021) Clinical Characteristics and HLA Genotypes in Chinese Patients with Anti-SLA/LP-Positive Autoimmune Hepatitis. An-nals of Translational Medicine, 9, Article 153. https://doi.org/10.21037/atm-20-8036
|
[8]
|
Mieli-Vergani, G., Ver-gani, D., Czaja, A.J., Manns, M.P., Krawitt, E.L., Vierling, J.M., et al. (2018) Autoimmune Hepatitis. Nature Reviews Disease Primers, 4, Article No. 18017. https://doi.org/10.1038/nrdp.2018.17
|
[9]
|
Ma, Y., Bogdanos, D.P., Hussain, M.J., et al. (2006) Polyclonal T-Cell Responses to Cytochrome P450IID6 Are Associated with Disease Activi-ty in Autoimmune Hepatitis Type 2. Gastroenterology, 130, 868-882.
https://doi.org/10.1053/j.gastro.2005.12.020
|
[10]
|
Eskandari-Nasab, E., Tahmasebi, A. and Hashemi, M. (2015) Meta-Analysis: The Relationship between CTLA-4 + 49 A/G Polymorphism and Primary Biliary Cirrhosis and Type I Autoimmune Hepatitis. Immunological Investigations, 44, 331-348. https://doi.org/10.3109/08820139.2014.1003651
|
[11]
|
Assis, D.N., Takahashi, H., Leng, L., et al. (2016) A Mac-rophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japa-nese Patients. Digestive Diseases and Sciences, 61, 3506- 3512. https://doi.org/10.1007/s10620-016-4322-z
|
[12]
|
Chaouali, M., Fernandes, V., Ghazouani, E., Pereira, L. and Kochkar, R. (2018) Association of STAT4, TGFβ1, SH2B3 and PTPN22 Polymorphisms with Autoimmune Hepatitis. Experimental and Molecular Pathology, 105, 279- 284. https://doi.org/10.1016/j.yexmp.2018.10.001
|
[13]
|
Webb, G., Chen, Y.Y., Li, K.K., et al. (2016) Single-Gene Association between GATA-2 and Autoimmune Hepatitis: A Novel Genetic Insight Highlighting Immunologic Pathways to Disease. Journal of Hepatology, 64, 1190-1193.
https://doi.org/10.1016/j.jhep.2016.01.017
|
[14]
|
Yousefi, A., Mahmoudi, E., Bidoki, A.Z., et al. (2016) IL4 Gene Polymorphisms in Iranian Patients with Autoimmune Hepatitis. Expert Review of Gastroenterology & Hepatology, 10, 659-663.
https://doi.org/10.1586/17474124.2016.1139449
|
[15]
|
Yousefi, A., Bidoki, A.Z., Shafioyoun, A., et al. (2019) Association of IL-10 and TGF-β Cytokine Gene Polymorphisms with Autoimmune Hepatitis. Clinics and Research in Hepatology and Gastroenterology, 43, 45-50.
https://doi.org/10.1016/j.clinre.2018.07.004
|
[16]
|
Racanelli, V. and Rehermann, B. (2006) The Liver as an Immu-nological Organ. Hepatology, 43, S54-S62.
https://doi.org/10.1002/hep.21060
|
[17]
|
Horst, A.K., Neumann, K., Diehl, L. and Tiegs, G. (2016) Modulation of Liver Tolerance by Conventional and Nonconventional Antigen-Presenting Cells and Regulatory Immune Cells. Cellular & Molecular Immunology, 13, 277-292.
https://doi.org/10.1038/cmi.2015.112
|
[18]
|
You, Z., Li, Y., Wang, Q., Zhao, Z., Li, Y., Qian, Q., et al. (2021) The Clinical Significance of Hepatic CD69+CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis. Hepatology, 74, 847-863.
https://doi.org/10.1002/hep.31739
|
[19]
|
Schultheiß, C., Steinmann, S., Lohse, A.W. and Binder, M. (2022) B Cells in Autoimmune Hepatitis: Bystanders or Central Players? Seminars in Immunopathology, 44, 411-427. https://doi.org/10.1007/s00281-022-00937-5
|
[20]
|
Czaja, A.J. (2021) Review Article: Targeting the B Cell Activa-tion System in Autoimmune Hepatitis. Alimentary Pharmacology & Therapeutics, 54, 902-922. https://doi.org/10.1111/apt.16574
|
[21]
|
Biewenga, M., Heidt, S., Vergunst, M., Marijnissen, C.M.J., de Man, R.A., van der Eijk, A.A., et al. (2022) B-Cell Activating Factor and IL-21 Levels Predict Treatment Response in Autoimmune Hepatitis. JHEP Reports, 4, Article ID: 100460. https://doi.org/10.1016/j.jhepr.2022.100460
|
[22]
|
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G. and Vergani, D. (2022) Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical Reviews in Allergy & Immunology, 63, 124-137.
https://doi.org/10.1016/j.jhep.2015.06.030
|
[23]
|
Ye, H., Li, T., Wang, H., Wu, J., Yi, C., Shi, J., et al. (2021) TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Ex-periments Validation. Frontiers in Immunology, 12, Article 649551. https://doi.org/10.3389/fimmu.2021.649551
|
[24]
|
Shin, H.Y., Yang, W., Chay, D.B., E, L., Chung, J.Y., Kim, H.S., et al. (2021) Tetraspanin 1 Promotes Endometriosis Leading to Ovarian Clear Cell Carcinoma. Molecular Oncolo-gy, 15, 987-1004.
https://doi.org/10.1002/1878-0261.12884
|
[25]
|
Zeng, A., Li, H., Guo, L., Gao, X., McKinney, S., Wang, Y., et al. (2018) Prospectively Isolated Tetraspanin+ Neoblasts Are Adult Pluripotent Stem Cells Underlying Planaria Regenera-tion. Cell, 173, 1593-1608.E20.
https://doi.org/10.1016/j.cell.2018.05.006
|
[26]
|
Bogdanos, D.P., Choudhuri, K. and Vergani, D. (2001) Molecular Mimicry and Autoimmune Liver Disease: Virtuous Intentions, Malign Consequences. Liver, 21, 225-232. https://doi.org/10.1034/j.1600-0676.2001.021004225.x
|
[27]
|
Christen, U. and Hintermann, E. (2019) Pathogens and Autoimmune Hepatitis. Clinical and Experimental Immunology, 195, 35-51. https://doi.org/10.1111/cei.13203
|
[28]
|
Ehser, J., Holdener, M., Christen, S., Bayer, M., Pfeilschifter, J.M., Hinter-mann, E., et al. (2013) Molecular Mimicry Rather than Identity Breaks T-Cell Tolerance in the CYP2D6 Mouse Model for Human Autoimmune Hepatitis. Journal of Autoimmunity, 42, 39-49. https://doi.org/10.1016/j.jaut.2012.11.001
|
[29]
|
Hintermann, E., Ehser, J. and Christen, U. (2012) The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice. Journal of Visualized Experiments, 60, e3644. https://doi.org/10.3791/3644
|
[30]
|
Gregorio, G.V., Choudhuri, K., Ma, Y., Pensati, P., Iorio, R., Grant, P., et al. (2003) Mimicry between the Hepatitis C Virus Polyprotein and Antigenic Targets of Nuclear and Smooth Muscle Anti-bodies in Chronic Hepatitis C Virus Infection. Clinical and Experimental Immunology, 133, 404-413. https://doi.org/10.1046/j.1365-2249.2003.02229.x
|
[31]
|
Gregorio, G.V., Choudhuri, K., Ma, Y., Vegnente, A., Mieli-Vergani, G. and Vergani, D. (1999) Mimicry between the Hepatitis B Virus DNA Polymerase and the Antigenic Targets of Nuclear and Smooth Muscle Antibodies in Chronic Hepatitis B Virus Infection. The Journal of Immunology, 162, 1802-1810.
https://doi.org/10.4049/jimmunol.162.3.1802
|
[32]
|
Kerkar, N., Choudhuri, K., Ma, Y., Mahmoud, A., Bogdanos, D.P., Muratori, L., et al. (2003) Cytochrome P4502D193-212: A New Immunodominant Epitope and Target of Virus/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease. The Journal of Immunology, 170, 1481-1489.
https://doi.org/10.4049/jimmunol.170.3.1481
|
[33]
|
Manns, M.P., Griffin, K.J., Sullivan, K.F. and Johnson, E.F. (1991) LKM-1 Autoantibodies Recognize a Short Linear Sequence in P450IID6, a Cytochrome P-450 Monooxygenase. Journal of Clinical Investigation, 88, 1370-1378.
|
[34]
|
Béland, K., Lapierre, P. and Alvarez, F. (2009) Influence of Genes, Sex, Age and Environment on the Onset of Autoimmune Hepatitis. World Journal of Gastroenterology, 15, 1025-1034. https://doi.org/10.3748/wjg.15.1025
|
[35]
|
Floreani, A., Restrepo-Jiménez, P., Francesca Secchi, M., et al. (2018) Etiopathogenesis of Autoimmune Hepatitis. Journal of Autoimmunity, 95, 133-143. https://doi.org/10.1016/j.jaut.2018.10.020
|
[36]
|
Vento, S., Garofano, T., Dolci, L., Di Perri, G., Concia, E. and Bassetti, D. (1991) Identification of Hepatitis A Virus as a Trigger for Autoimmune Chronic Hepatitis Type 1 in Suscep-tible Individuals. The Lancet, 337, 1183-1187.
https://doi.org/10.1016/0140-6736(91)92858-Y
|
[37]
|
Hilzenrat, N., Zilberman, D., Klein, T., Zur, B. and Sikuler, E. (1999) Autoimmune Hepatitis in a Genetically Susceptible Patient: Is It Triggered by Acute Viral Hepatitis A? Digestive Diseases and Sciences, 44, 1950-1952.
|
[38]
|
Bogdanos, D.P. and Dalekos, G.N. (2008) Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s. Current Medicinal Chemistry, 15, 2285-2292. https://doi.org/10.2174/092986708785747508
|
[39]
|
Aceti, A., Mura, M.S., Babudieri, S. and Bacciu, S.A. (1995) A Young Woman with Hepatitis after a Sore Throat. The Lancet, 346, 1603. https://doi.org/10.1016/S0140-6736(95)91932-5
|
[40]
|
Kojima, K., Nagayama, R., Hirama, S., Maeda, T., Takikawa, H., Miyake, K., Yamanaka, M. and Shiga, J. (1999) Epstein-Barr Virus Infection Resembling Autoimmune Hepatitis with Lactate Dehydrogenase and Alkaline Phosphatase Anomaly. Journal of Gastroenterology, 34, 706-712. https://doi.org/10.1007/s005350050324
|
[41]
|
Nobili, V., Comparcola, D., Sartorelli, M.R., Devito, R. and Marcelli-ni, M. (2003) Autoimmune Hepatitis Type 1 after Epstein-Barr Virus Infection. The Pediatric Infectious Disease Journal, 22, 387.
https://doi.org/10.1097/01.inf.0000060825.68086.9c
|
[42]
|
Vento, S., Guella, L., Mirandola, F., Cainelli, F., Di Per-ri, G., Solbiati, M., Ferraro, T. and Concia, E. (1995) Epstein-Barr Virus as a Trigger for Autoimmune Hepatitis in Sus-ceptible Individuals. The Lancet, 346, 608-609.
https://doi.org/10.1016/S0140-6736(95)91438-2
|
[43]
|
Christen, U. and Hintermann, E. (2014) Pathogen Infection as a Possible Cause for Autoimmune Hepatitis. International Reviews of Immunology, 33, 296-313. https://doi.org/10.3109/08830185.2014.921162
|
[44]
|
Liwinski, T., Casar, C., Ruehlemann, M.C., Bang, C., Sebode, M., Hohenester, S., Denk, G., Lieb, W., Lohse, A.W., Franke, A. and Schramm, C. (2020) A Disease-Specific Decline of the Relative Abundance of Bifidobacterium in Patients with Autoimmune Hepatitis. Alimentary Pharmacology & Therapeutics, 51, 1417-1428.
https://doi.org/10.1111/apt.15754
|
[45]
|
Wei, Y., Li, Y., Yan, L., Sun, C., Miao, Q., Wang, Q., Xiao, X., Lian, M., Li, B., Chen, Y., Zhang, J., Li, Y., Huang, B., Li, Y., Cao, Q., Fan, Z., Chen, X., Fang, J.Y., Gershwin, M.E., Tang, R. and Ma, X. (2020) Alterations of Gut Microbiome in Autoimmune Hepatitis. Gut, 69, 569-577. https://doi.org/10.1136/gutjnl-2018-317836
|
[46]
|
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G. and Vergani, D. (2021) Autoimmmune Hepatitis. Cellular & Molecular Immunology, 19, 158-176. https://doi.org/10.1038/s41423-021-00768-8
|
[47]
|
Swanson, K.S., Gibson, G.R., Hutkins, R., Reimer, R.A., Reid, G., Verbeke, K., Scott, K.P., Holscher, H.D., Azad, M.B., Delzenne, N.M. and Sanders, M.E. (2020) The Internationa Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Synbi-otics. Nature Reviews Gastroenterology & Hepatology, 17, 687-701. https://doi.org/10.1038/s41575-020-0344-2
|
[48]
|
Liu, Q., Tian, H., Kang, Y., Tian, Y., Li, L., Kang, X., et al. (2021) Probiotics Alleviate Autoimmune Hepatitis in Mice through Modulation of Gut Microbiota and Intestinal Permea-bility. The Journal of Nutritional Biochemistry, 98, Article ID: 108863. https://doi.org/10.1016/j.jnutbio.2021.108863
|
[49]
|
Kang, Y., Kuang, X., Yan, H., Ren, P., Yang, X., Liu, H., Liu, Q., Yang, H., Kang, X., Shen, X., Tong, M., Li, L., Wang, X., Guo, L., Ma, J., Zhang, F. and Fan, W. (2023) A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway. mSystems, 8, e0112722. https://doi.org/10.1128/msystems.01127-22
|
[50]
|
Björnsson, E., Talwalkar, J., Treeprasertsuk, S., Kamath, P.S., Takahashi, N., Sanderson, S., Neuhauser, M. and Lindor, K. (2010) Drug-Induced Autoimmune Hepatitis: Clinical Characteristics and Prognosis. Hepatology, 51, 2040- 2048. https://doi.org/10.1002/hep.23588
|
[51]
|
Czaja, A.J. (2011) Drug-Induced Autoimmune-Like Hepatitis. Digestive Diseases and Sciences, 56, 958-976.
https://doi.org/10.1007/s10620-011-1611-4
|
[52]
|
Saitis, A., Gatselis, N., Zachou, K. and Dalekos, G.N. (2013) Use of TNFα Antagonists in Refractory AIH: Revealing the Unforeseen. Journal of Hepatology, 59, 197-198. https://doi.org/10.1016/j.jhep.2013.02.029
|
[53]
|
Zachou, K., Muratori, P., Koukoulis, G.K., Granito, A., Gatselis, N., Fabbri, A., Dalekos, G.N. and Muratori, L. (2013) Review Article: Autoimmune Hepatitis—Current Management and Challenges. Alimentary Pharmacology & Therapeutics, 38, 887-913. https://doi.org/10.1111/apt.12470
|
[54]
|
高晓琴, 赵永勋, 任茜, 等. 药物诱导的自身免疫性肝炎的研究进展[J]. 临床肝胆病杂志, 2017, 33(11): 2222- 2225.
|
[55]
|
He, Y. and Zhan, J. (2013) Advances in Drug—Induced Autoimmune Hepatitis. Journal of Practical Hepa-tology, 16, 178-180. (In Chinese)
|
[56]
|
Paronetto, F. (1993) Immunologic Reactions in Alcoholic Liver Disease. Semi-nars in Liver Disease, 13, 183-195.
https://doi.org/10.1055/s-2007-1007348
|
[57]
|
Xu, D., Thiele, G.M., Beckenhauer, J.L., Klassen, L.W., Sorrell, M.F. and Tuma, D.J. (1998) Detection of Circulating Antibodies to Malondialdehyde-Acetaldehyde Adducts in Etha-nol-Fed Rats. Gastroenterology, 115, 686-692.
https://doi.org/10.1016/S0016-5085(98)70148-9
|
[58]
|
Luong, K.V. and Nguyen, L.T. (2013) The Role of Vitamin D in Autoimmune Hepatitis. Journal of Clinical Medicine Research, 5, 407-415. https://doi.org/10.4021/jocmr1505w
|
[59]
|
Invernizzi, P., Pasini, S., Selmi, C., Gershwin, M.E. and Podda, M. (2009) Female Predominance and X Chromosome Defects in Autoimmune Diseases. Journal of Autoimmunity, 33, 12-16. https://doi.org/10.1016/j.jaut.2009.03.005
|
[60]
|
Invernizzi, P., Miozzo, M., Battezzati, P.M., Bianchi, I., Gra-ti, F.R., Simoni, G., Selmi, C., Watnik, M., Gershwin, M.E. and Podda, M. (2004) Frequency of Monosomy X in Women with Primary Biliary Cirrhosis. The Lancet, 363, 533-535. https://doi.org/10.1016/S0140-6736(04)15541-4
|
[61]
|
Miozzo, M., Selmi, C., Gentilin, B., Grati, F.R., Sirchia, S., Oertelt, S., Zuin, M., Gershwin, M.E., Podda, M. and Invernizzi, P. (2007) Preferential X Chromosome Loss But Ran-dom Inactivation Characterize Primary Biliary Cirrhosis. Hepatology, 46, 456-462. https://doi.org/10.1002/hep.21696
|
[62]
|
Czaja, A.J., dos Santos, R.M., Porto, A., Santrach, P.J. and Moore, S.B. (1998) Immune Phenotype of Chronic Liver Disease. Digestive Diseases and Sciences, 43, 2149-2155. https://doi.org/10.1023/A:1018836004279
|
[63]
|
McFarlane, I.G. and Heneghan, M.A. (2004) Autoimmunity and the Female Liver. Hepatology Research, 28, 171-176.
https://doi.org/10.1016/j.hepres.2003.12.002
|
[64]
|
Whitacre, C.C., Reingold, S.C. and O’Looney, P.A. (1999) A Gender Gap in Autoimmunity. Science, 283, 1277-1278.
https://doi.org/10.1126/science.283.5406.1277
|